AmBisome for fungal infections in children with blood cancer
Part of Infections clinical trials.
This study follows children and teens with blood cancers who got a fungal infection while on preventive antifungal medicine. It looks at how well liposomal amphotericin B (AmBisome) works and how safe it is for them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 1 month and 18 years old.
- You have a blood cancer (like leukemia or lymphoma).
- You've been taking a preventive antifungal medicine (triazole or echinocandin) for at least 7 days.
- You developed a new fungal infection despite that prevention.
- You have not used amphotericin B in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether amphotericin B can treat new fungal infections that develop in people with blood cancers even after they have taken preventive antifungal medicine. It may help patients who have a confirmed or suspected fungal infection while on that prevention.
This trial tests a combination of antifungal medicines (liposomal amphotericin B and either isavuconazole or posaconazole) for people with blood cancers who develop a fungal infection despite taking preventive antifungal drugs. It aims to find a better treatment for these difficult infections.
This study looks at how a medicine called L-AmB (a type of amphotericin B, used to treat fungal infections) works in patients who are on ECMO. The goal is to find the right dose for people in your situation.
This trial looks at how a specific antifungal medicine, called liposomal amphotericin B, given over a longer period, helps prevent serious fungal infections in people undergoing treatment for cancer or receiving a stem cell transplant. It may be an option if you are at high risk for these infections.
This trial tests a low dose of an antifungal medicine (liposomal amphotericin B) to prevent serious fungal infections in children whose immune system is weak after cancer treatment or a stem cell transplant. It's for kids aged 3 to 17 who are at high risk for these infections.
This study looks at how safe and effective a medicine called liposomal amphotericin B is for treating mold infections in people who have had a liver transplant. It may help doctors understand better ways to fight these serious infections.
Hear when a new Fungal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.